Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Organic Letters|August 10, 2000
A new photocleavable linker in solid-phase chemistry for ether cleavageGlatthar, GieseOrganic Letters|April 12, 2003
Sequentially photocleavable protecting groups in solid-phase synthesisMartin Kessler, Ralf Glatthar, Bernd Giese, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK ProfileDavid Carcache, Ivo Vranesic, Joachim Blanz, et al.Bioorganic & Medicinal Chemistry Letters|November 26, 2009
Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activityCarsten Spanka, Ralf Glatthar, Sandrine Desrayaud, et al.Journal of the American Chemical Society|May 9, 2002
Development of an enantioselective synthetic route to neocarzinostatin chromophore and its use for multiple radioisotopic incorporationAndrew G Myers, Ralf Glatthar, Marlys Hammond, et al.The Journal of Biological Chemistry|April 29, 2015
The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain FoldSascha Gutmann, Alexandra Hinniger, Gabriele Fendrich, et al.Journal of Medicinal Chemistry|May 1, 2024
Novel Inhibitory Site Revealed by XAP044 Mode of Action on the Metabotropic Glutamate 7 Receptor Venus Flytrap DomainNunzia Cristiano, Alexandre Cabayé, Isabelle Brabet, et al.Journal of Medicinal Chemistry|August 10, 2016
Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase InhibitorsRalf Glatthar, Aleksandar Stojanovic, Thomas Troxler, et al.The Journal of Biological Chemistry|March 6, 2014
Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behaviorChristine E Gee, Daniel Peterlik, Christoph Neuhäuser, et al.Journal of Medicinal Chemistry|August 14, 2020
Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition AssayThomas Knoepfel, Pierre Nimsgern, Sébastien Jacquier, et al.Pageof 2